Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese Updated Sunday, August 28, 2016
 Services
Submit a manuscript
Subscribe
Individuals
Institutions
Response
Send response
Read responses
Reprint
Advance online publication
Sign up for e-alert
JCIM job opportunities
Contact JCIM
 Information For
Readers
Authors
Reviewers
Advertisers
 About JCIM
Journal description
Editorial policy
Privacy policy
Copy right
Editorial staff
 Language Polishing
Journal of Chinese Integrative Medicine: 2009; 7(2): 151-156
DOI: 10.3736/jcim20090211
Effects of Salviae miltiorrhizae and salvianolic acid B on microcirculation of liver in mice with portal hypertension
1. Tian TIAN (Institute of Liver Disease, Key Laboratory of Liver and Kidney Disease of the Ministry of Education, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China )
2. Lie-ming XU (Institute of Liver Disease, Key Laboratory of Liver and Kidney Disease of the Ministry of Education, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China E-mail: xulieming@shutcm.edu.cn)
Objective: To observe the effects of Salviae miltiorrhizae and its component, salvianolic acid B (SA-B), on the microcirculation of liver in mice with portal hypertension induced by endothelin-1 (ET-1).
Methods: Eighty-four Kunming mice were randomly divided into 7 groups: untreated group, endothelin A receptor (ETAR) blocker group, Astragali mongolici group, Astragalus polysaccharides (APS) group, Corydalis Yanhusuo group, Salviae miltiorrhizae group and SA-B group. There were 12 mice in each group. Mice were pretreated with a corresponding equivalent volume of drug or distilled water for 3 days, and then the portal hypertension in mice was induced by continuous injection of ET-1 into coccygeal vein using a micro-injection pump. Six mice in each group were used to observe the average liver blood flow volume by laser-Doppler flow instrument before and after injection of ET-1, and the other six rats were used to observe the hepatic microcirculation velocity in vivo by an inverted microscope.
Results: The average blood flow of liver in mice decreased in each group after ET-1 injection. But the changes of average blood flow in the SA-B group and the ETAR blocker group were less than that in the untreated group (P
0.01). The changes of average blood volume in the Astragali mongolici group and the APS group were similar to that in the untreated group, but more than that in the SA-B group after injection of ET-1. The change of average blood flow in the SA-B group showed no significant difference when compared with the ETAR blocker group. The microcirculatory flow velocity in liver also decreased in each group after ET-1 injection. But the changes of microcirculatory flow velocity in the SA-B group and the ETAR blocker group were less than that in the untreated group (P0.05, P0.01). There were no significant differences in the changes of microcirculatory flow velocity among the Salviae miltiorrhizae group, the SA-B group and the ETAR blocker group.
Conclusion: Salviae miltiorrhizae and SA-B can decrease the average blood flow and microcirculatory flow velocity in liver in mice with portal hypertension, which may be one of the mechanisms of Salviae miltiorrhizae and SA-B in decreasing portal hypertension.
Welcome to JCIM! You are the number 9936 reader of this article!
Download Article:
[Full Text]      [PDF]      [Chinese]      [Previous]      [Next]      [This Issue]
Please cite this article as:
Tian T, Xu LM. Effects of Salviae miltiorrhizae and salvianolic acid B on microcirculation of liver in mice with portal hypertension. J Chin Integr Med/Zhong Xi Yi Jie He Xue Bao. 2009; 7(2): 151-156.
References:
1He TL, Wu ZY. Current study of liver fibrosis with portal hypertension[J].Zhonghua Wai Ke Gan Dan Za Zhi, 2006, 12(4): 287-288. Chinese.
2Zhao JM, Zhou GD, Li WS, Wang SS, Sun YL, Yang JF, Pan D, Zhang LX, Guo SG, Niu JZ, Chen JM. An experimental study on the mechanism of anti-hepatic fibrosis with Chinese medicinal herbs Fufangbiejia-ruanganpian[J].Jie Fang Jun Yi Xue Za Zhi, 2004, 29(7): 560-562. Chinese with abstract in English.
3Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors[J].J Clin Invest, 1998, 102(3): 538-549.  .
4Zhou Y, Gu J, Xu LM. Effects of salvianolic acid B on elevated portal pressure and hepatic endothelin-1 level in rat model of hepatocirrhosis[J].Zhongguo Zhong Xi Yi Jie He Xiao Hua Za Zhi, 2007, 15(1): 4-7. Chinese with abstract in English.
5Chen HF. Microcirculation blood flow quantitative measurement system[M]. Hangzhou: Master Thesis of Zhejiang University, 2002. 6. Chinese.
6Chen SY. Current study on gene therapy for liver fibrosis[J].Lin Chuang Gan Dan Bing Za Zhi, 2007, 23(5): 387-388. Chinese.
7Liu XY. Current status of treatment of liver cirrhosis with portal hypertension[J].Zhongguo Xian Dai Shou Shu Xue Za Zhi, 2003, 7(1): 15-17. Chinese.
8Sherman IA, Pappas SC, Fisher MM. Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis[J].Am J Physiol, 1990, 258(2 Pt 2): H460-H465.  .
9Leng XS. Prospects of basic researches concerning portal hypertension[J].Wai Ke Li Lun Yu Shi Jian, 2002, 7(4): 258-260. Chinese.
10Niki T, Pekny M, Hellemans K, Bleser PD, Berg KV, Vaeyens F, Quartier E, Schuit F, Geerts A. Class Ⅵ intermediate filament protein nestin is induced during activation of rat hepatic stellate cells[J].Hepatology, 1999, 29(2): 520-527.  .
11Ikura Y, Ohsawa M, Naruko T, Muraguchi T, Hirayama M, Suekane T, Fukushima H, Sugama Y, Shirai N, Kayo S, Yoshimi N, Ehara S, Tanzawa K, Ueda M. Expression of the hepatic endothelin system in human cirrhotic livers[J].J Pathol, 2004, 204(3): 304-310.  .
12Tsai YT, Lin HC, Yang MC, Lee FY, Hou MC, Chen LS, Lee SD. Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function[J].J Hepatol, 1995, 23(6): 681-688.  .
13Zhou Y, Gu J, Xu LM. Effect and mechanism of salvianolic acid B in attenuating elevated portal pressure in a rat model of portal hypertension induced by endothelin-1[J]. J Chin Integr Med, 2007, 5(1): 61-64. Chinese with abstract in English.
14Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Huang DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Tang BZ, He J. Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B[J]. J Chin Integr Med, 2003, 1(2): 89-98, 102. Chinese with abstract in English.
15Tao YY, Liu CH. Progress of research on mechanism of Salvia miltiorrhiza and its chemical ingredients against liver fibrosis[J]. J Chin Integr Med, 2004, 2(2): 145-148. Chinese.

 Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese
Copyright © 2003-2012 by JCIM Press. All rights reserved. ISSN 1672-1977